Top Ten Tech Trends: Getting the Green Light on Clinician-to-Clinician Texting
3 Keys To Successfully Enabling Electronic Prescribing Of Controlled Substances
E-Rx Tool for Controlled Substances Launches, Integrates with EHRs
Imprivata Achieves Revenue Growth of 32% for the First Quarter of 2015 and Raises Annual Guidance
Adoption of Single Sign-On with Desktop Virtualization in Healthcare Continues to Soar, According to New Research from Imprivata
Imprivata Announces First Quarter 2016 Financial Results, Revenue Growth of 23%
Patient ID errors rising, common in hospital settings
National e-prescribing bill gains support as Trump declares opioid state of emergency.
Cerner honors Imprivata with 2017 partner of the year award
